An official website of the United States government
06/06/2024: Lab Advisory: Novel Influenza A Virus Biosafety Guidance Update
Audience: Clinical Laboratory Professionals
Level: Laboratory Update
On June 6, 2024, the U.S. Centers for Disease Control and Prevention (CDC) updated the laboratory biosafety guidelines for handling and processing specimens associated with Novel Influenza A viruses webpage to include additional information about risk assessment and mitigation, diagnostic testing, and decontamination and waste management. The risk posed by Novel Influenza A viruses to the public remains low.
We encourage you to review the webpage and share this message widely with your networks.
Opt in to receive updates from the CDC Laboratory Outreach Communication System.
Online Resources
- Avian Flu | CDC
- Laboratory Biosafety Guidelines for Handling and Processing Specimens Associated with Novel Influenza A Viruses, Including Potential A(H5N1) Virus
- Interim Guidance on Testing and Specimen Collection for Patients with Suspected Infection with Novel Influenza A Viruses with the Potential to Cause Severe Disease in Humans
- Select Agents and Toxins Exemption: H5 Avian Influenza Virus | USDA
- Lab Advisory: CDC Issues Health Alert for Highly Pathogenic Avian Influenza A(H5N1) Virus | LOCS Message
Questions?
- If you are a clinical or public health laboratory professional, contact LOCS.
- For media inquiries, contact the CDC Newsroom.
- For all other questions, contact CDC-INFO.
Thank you,
The Laboratory Outreach Communication System
Laboratory Outreach Communication System (LOCS) | Division of Laboratory Systems (DLS)
Center for Laboratory Systems and Response (CLSR)
Centers for Disease Control and Prevention (CDC)